Somewhat Favorable News Coverage Somewhat Unlikely to Impact Cardinal Health (CAH) Stock Price
News articles about Cardinal Health (NYSE:CAH) have been trending somewhat positive on Wednesday, according to Accern. The research firm scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cardinal Health earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned media stories about the company an impact score of 45.8383244287703 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the media stories that may have impacted Accern Sentiment’s analysis:
- Form PX14A6G CARDINAL HEALTH INC Filed by: UAW Retiree Medical Benefits Trust (streetinsider.com)
- Investor group presses US drug companies on opioid controls – Reuters (reuters.com)
- S&P 500 Dividend Aristocrats Gains Led By Walgreens, AT&T, & Federal (seekingalpha.com)
- Investor group presses U.S. drug companies on opioid controls (finance.yahoo.com)
- Stocks That Fell to 3-Year Lows in the Week of Oct. 27 – GuruFocus.com (gurufocus.com)
CAH has been the subject of several recent research reports. BidaskClub cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 11th. Cowen and Company raised Cardinal Health to a “buy” rating and set a $74.00 price objective on the stock in a report on Tuesday, October 10th. Jefferies Group LLC reissued a “hold” rating and issued a $77.00 price objective on shares of Cardinal Health in a report on Thursday, July 27th. Needham & Company LLC reissued a “hold” rating on shares of Cardinal Health in a report on Sunday, September 10th. Finally, Robert W. Baird reissued a “hold” rating and issued a $73.00 price objective on shares of Cardinal Health in a report on Sunday, September 17th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $75.72.
Shares of Cardinal Health (NYSE:CAH) opened at 61.90 on Wednesday. The stock has a 50 day moving average price of $66.30 and a 200-day moving average price of $71.33. The firm has a market capitalization of $19.59 billion, a price-to-earnings ratio of 15.36 and a beta of 0.86. Cardinal Health has a 52 week low of $60.69 and a 52 week high of $84.88.
Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.07. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The firm had revenue of $32.97 billion during the quarter, compared to the consensus estimate of $32.73 billion. During the same period last year, the business posted $1.14 EPS. Cardinal Health’s quarterly revenue was up 5.0% on a year-over-year basis. On average, analysts anticipate that Cardinal Health will post $4.95 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Sunday, October 15th. Investors of record on Monday, October 2nd were paid a $0.4624 dividend. This represents a $1.85 annualized dividend and a yield of 2.99%. The ex-dividend date of this dividend was Friday, September 29th. Cardinal Health’s payout ratio is currently 45.79%.
TRADEMARK VIOLATION WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Impact Cardinal Health (CAH) Stock Price” was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://theolympiareport.com/2017/11/01/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-cardinal-health-cah-stock-price.html.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.